A prospective study on prediction of sensitivity to trastuzumab using gene expression of peripheral blood mononuclear cells
Not Applicable
- Conditions
- bresat cancer
- Registration Number
- JPRN-UMIN000002660
- Lead Sponsor
- Chikako Shimizu, Kenji Tamura
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1. uncontrolled CNS metastasis 2. co-existence of heart failure or past history of decline in cardiac function during trastuzumab treatment 3. pregnant women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method response rate after enrichment by gene signature
- Secondary Outcome Measures
Name Time Method